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Background Severe acute respiratory illness (SARI) is recognized
as an important cause of morbidity, mortality, and hospitalization
among children in developing countries. Little is known, however,
in tropical countries like Cameroon about the cause and seasonality
of respiratory infections, especially in hospitalized
settings.Objectives: Our study investigates the viral etiology and
seasonality of SARI in hospitalized children in Yaounde, Cameroon.
Methods Prospective clinic surveillance was conducted to identify
hospitalized children aged ≤15 years presenting with respiratory
symptoms ≤5-day duration. Demographic and clinical data, and
respiratory specimens were collected. Nasopharyngeal samples were
tested for 17 respiratory viruses using a multiplex polymerase chain
reaction. The viral distribution and demographic data were
statistically analyzed.
Results From September 2011 through September 2013, 347
children aged ≤15 years were enrolled. At least one virus was
identified in each of 654% children, of which 295% were
coinfections; 273% were positive for human adenovirus (hAdV),
132% for human respiratory syncytial virus (hRSV), 115% for
rhinovirus/enterovirus (RV/EV), 106% for human bocavirus
(hBoV), 98% for influenza virus (Inf), 66% for human
parainfluenza virus (hPIV), 57% for human coronavirus (hCoV),
and 23% for human metapneumovirus (hMPV). While hRSV
showed seasonal patterns, hAdV and RV/EV were detected
throughout the year and no evident temporal patterns were
observed for the remaining viruses.
Conclusion Respiratory viruses were associated with a high burden
of hospitalizations among children in Cameroon. Nevertheless,
additional studies evaluating asymptomatic Cameroonian children
will be important in understanding the relationship between viral
carriage and disease.
Keywords Africa, Cameroon, etiology, severe acute respiratory
infections, virus.
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Introduction
Severe acute respiratory illness (SARI) is the leading cause of
hospitalization, morbidity, and mortality in children younger
than 5 years throughout the world. The burden of these
infections is particularly important in developing countries
with a meta-analysis estimating that 265 000 (95% CI
160 000–450 000) in-hospital deaths took place in 2010
with 99% of those deaths occurring in developing countries.1
Although there is little information on the causes of these
respiratory illnesses in developing countries, available data
indicate that viral agents play an important role globally.2 A
meta-analysis estimates that hRSV causes 338 million
infections each year among children younger than 5 years.
About 34 million of these cases require hospital admission,
and an estimated 66 000–199 000 of children die with 99%
of deaths occurring in developing countries.3 Many other
viruses such as influenza viruses, rhinoviruses (RV), human
parainfluenza viruses (hPIV), human adenoviruses (hAdV),
human coronaviruses (hCoV-OC43, hCoV-229E, hCoV-
NL63, and hCoV-HKU1), and enteroviruses (EV) have also
been implicated worldwide.2,4,5 Discovered recently, human
metapneumoviruses (hMPVs) and human bocaviruses
(hBoVs) are viruses resulting in similar symptoms. Other
emergent viruses such as SARS-CoV and MERS-CoV are
responsible for more severe symptoms like respiratory
distress syndrome.6–8 Real-time reverse-transcription poly-
merase chain reaction (rRT-PCR) assays have been shown to
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be a sensitive and specific tool for the detection of these
viruses. Furthermore, the introduction of multiplex rRT-
PCR enables the set-up of assays detecting two or more
targets in single clinical specimen.9,10
In 2007, the Centre Pasteur du Cameroun (CPC) began
implementing sentinel surveillance for influenza in Camer-
oon. This surveillance system has enabled a better under-
standing of the epidemiology of influenza in the
country.11,12 Even though our recent publication has
demonstrated that those respiratory viruses play an
important role in patients consulting our sentinel sites,13
there remains a lack of information regarding patients
hospitalized with SARI.
This study was conducted to gain new insights into the
timeliness of virus circulation and viral etiology among
children aged ≤15 years, hospitalized for SARI.
Materials and methods
Study design
This prospective observational study was conducted in the
pediatric service of ‘Centre Hospitalier d’Essos’ in Yaounde,
Cameroon. This central region has an equatorial climate with
a defined moderate rainfall during March–June and intense
precipitation during September–November.
Subjects
Children aged less than or equal to 15 years hospitalized for
SARI were daily recruited in our study. A total of 347
patients were enrolled by experienced nurses or physicians
during a 2-year period between September 2011 and
September 2013. SARI was defined according to a previously
suggested WHO case definition14 with a history of symptoms
of <5 days. These criteria of hospitalized patient inclusion
were as follows: fever >38°C and cough and/or sore throat.
Ethical considerations
Children were enrolled only after an informed written
consent was obtained from their parents or legal guardians.
This study was part of a global study aimed at assessing risk
factors associated with severe influenza in Cameroon (IMMI
Project), which was reviewed and approved by the National
Research Ethics Committee and the Ministry of Health of
Cameroon.
Study and laboratory procedures
Demographic and clinical information was obtained from
participants using a standardized questionnaire.
Nasopharyngeal swab specimens were collected from
hospitalized children and transported to the CPC as previ-
ously described.13 Viral RNA and DNA were extracted using
QIAamp Viral RNA Mini kit and QIAamp DNA Mini kit
(Qiagen, Hilden, Germany), respectively, following the
manufacturers’ instructions. A final elution volume of
60 ll of RNA and 200 ll of DNA were stored at –80°C till
testing by multiplex PCR/RT-PCR. Testing for influenza A
and B viruses were conducted, and influenza A virus-positive
specimens were subtyped according to the method developed
by US Centers for Disease Control and Prevention (CDC).15
Then, the detection of 14 non-influenza respiratory viruses,
including hMPV, hRSV, hPIV (1–4), EV, RV, hCoV-OC43,
hCoV-229E, hCoV-NL63, hCoV-HKU1, hAdV, and hBoV
were performed by 4 duplex rRT-PCR, using a commercially
available Respiratory Multi Well System r-geneTM
(bioMerieux, Lyon, France) following the manufacturer’s
instructions. PCR amplifications were performed on ABI
7500 Fast (Applied Biosystems, Foster City, CA, USA). A
patient was considered to have a single viral infection if only
one pathogen was detected in the specimens. In case of more
than one viral pathogen detected, patients were considered to
have viral coinfections.
Statistical analysis
The data obtained and the laboratory results were anon-
ymized and entered into a database prepared with Micro-
soft Excel (Microsoft, Washington, DC, USA). The database
was then checked and cleaned for abnormal wrongful entries.
We analyzed the demographics of the study subjects and the
positive cases, as well as the clinical characteristics of all
respiratory viruses. Proportions were compared using a chi-
squared or the Fisher exact test. We analyzed the clinical and
coinfection characteristics of positive according to the
negative patients for respiratory viruses using a stepwise
logistic regression model. Uncertainty was expressed as 95%
confidence intervals (CIs). Statistical analysis was performed
with the R program version 2151, and P-values of 005 or
less were considered statistically significant.
Results
Demographic characteristics
During the study period, 374 hospitalized children with SARI
aged 0–15 years were enrolled. As 27 patients were excluded
due to insufficient material for analysis of all viruses, 347
(92,8%) subjects were analyzed. The median age of the
patients was 15 years (IQR: 075–30 years). Most patients
(884%) were below 5 years of age, with 131 (378%)
children ≤1 year, 100 (288%) children aged [1–2] years, 76
(219%) children aged [2–5] years, and 40 (115%) children
aged [5–15] years. Half of patients (180 [519%]) were male.
Among the 347 hospitalized participants with SARI, the most
common respiratory symptoms were cough (859%, 298/
347), rhinorrhea (784%, 272/347), fatigue (579%, 201/347),
and wheezing (418%, 145/347). Demographic data and
clinical characteristics of the 347 cases studied are summa-
rized in Table 1.
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Clinical characteristics and viral agents identified
Respiratory viruses were observed in 227 [654%; 95%CI:
601–704] of the 347 samples analyzed for the 17 respiratory
viruses tested. The most frequently identified pathogen was
hAdV (274%, 95/347) followed by hRSV (133%, 46/347),
EV/RV (115%, 40/347), hBoV (107%, 37/347), influenza
(98%, 34/347; consisted of influenza A/H3N2 [63%, 22/
347], influenza B [23%, 8/347], influenza A/H1N1/2009
[12%, 4/347]), hPIV (66%, 23/347), hCoV (58%, 20/347),
and hMPV (4%, 14/347) (Figure 1).
A majority of SARI was observed among children aged
≤5 years (907%, 206/227), and the proportions infected
were significantly negatively associated with age (odds ratio
[OR], 091; 95% CI, 084–099, P = 003). There were no
significant differences in terms of gender between patients
infected with different viruses. Influenza virus were more
frequently detected in the individuals over 1 year (P = 004).
For the remaining viruses, there was no difference between
rate of infection and age (Table 2).
Among positive samples, single viral infection accounted
for 705% (160/227) of cases, whereas infections with
multiple viruses were observed in 295% (67/227), including
53 double infections, 13 triple infections, and one quadruple
infection. Specific viruses detected in the study population
of 347 hospitalized children are listed in Table 3, in
descending detection rate. The mean age and age group
distribution of patients with multiple viral infections were
not significantly different from those of group with single
infection (Table 2). HAdV, hRSV, Influenza and hMPV
were more frequent in single infections whereas RV/EV,
hBoV, hPIV, and hCoV were more frequent in mixed
infections (Figure 2).
Table 1. Demographic and clinical characteristics of all participants (N = 347)
Characteristics
SARI recruited
(n = 347)
Negative samples
(n = 120)
Respiratory viruses detected
Total (n = 227) 1 (n = 160) >1 (n = 67)
Sex
Male 180 (519) 61 (508) 119 (524) 85 (531) 34 (508)
Female 167 (481) 59 (492) 108 (476) 75 (469) 33 (492)
Age
≥ 1 Year 131 (378) 43 (358) 88 (388) 59 (369) 29 (433)
[1–2] years 100 (288) 32 (267) 68 (300) 50 (312) 18 (269)
[2–5] years 76 (219) 26 (217) 50 (220) 35 (219) 15 (224)
[5–15] years 40 (115) 19 (158) 21 (92) 16 (100) 5 (74)
Symptoms
Cough 298 (859) 99 (825) 199 (877) 137 (856) 62 (925)
Rhinorrhea 272 (784) 89 (742) 183 (806) 129 (806) 54 (806)
Fatigue 201 (579) 60 (50) 141 (621) 104 (650) 37 (552)
Wheezing 145 (418) 49 (408) 96 (423) 67 (419) 29 (433)
Vomiting 131 (378) 42 (35) 89 (392) 63 (394) 26 (388)
Diarrhea 100 (288) 37 (308) 63 (278) 46 (288) 17 (254)
Sore throat 75 (216) 39 (325) 36 (159) 26 (163) 10 (149)
Headache 46 (133) 23 (192) 23 (101) 21 (131) 2 (30)
Conjunctivitis 36 (104) 12 (10) 24 (106) 185 (113) 6 (90)
Arthralgia 29 (84) 12 (10) 17 (75) 16 (100) 1 (15)
Cutaneous rash 26 (75) 11 (92) 15 (66) 14 (88) 1 (15)
Myalgia 17 (49) 10 (83) 7 (31) 6 (38) 1 (15)
Earache 13 (37) 5 (42) 8 (35) 6 (38) 2 (30)
Data are number and percentage in brackets.
Figure 1. Detection rate of each virus or group of viruses in 347
respiratory samples. Positive cases are the sum of single and mixed
infections for each virus or group of viruses.
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In a binary logistic regression, positive samples was
negatively associated only with headaches (P = 0003, odds
ratio [OR], 008; 95% CI, 001–03). No other clinical
symptoms were associated with the positive patients, nor
with any other specific viruses detected or coinfections.Sea-
sonality.
The study also investigated the monthly distribution of
viruses. The seasonal variations of the viral respiratory
infections are shown in figure 2. In the first period from
September 2011 to November 2012, the average number of
samples collected monthly was 187, whereas in the second
period from December 2012 to September 2013 the number
of enrolled cases was much lower, the average number of
samples collected monthly being 66. However, hRSV showed
a pronounced seasonality, with peaks during the rainy season
from September to December. The circulation of influenza
viruses was similar to hRSV although a few cases were
detected outside the rainy season peak. RV/EV was detected
almost year-round with peak activity in the rainy season
between September and December corresponding to a higher
Table 2. Detection rate and age-specific distribution of each virus or group of viruses detected and rate of coinfection
Total [0–1] year [1–2] years [2–5] years [5–15] years P-value
N 347 131 100 76 40
HAdV 95 (274) 40 (305) 27 (27) 20 (263) 8 (20) 061
HRSV 46 (133) 20 (153) 11 (11) 12 (158) 3 (75) 047
RV/EV 40 (115) 16 (122) 15 (15) 7 (92) 2 (5) 037
HBoV 37 (107) 16 (122) 9 (9) 8 (105) 4 (10) 088
Influenza 34 (98) 6 (46) 15 (15) 9 (118) 4 (10) 004
HPIV 23 (66) 9 (69) 4 (4) 8 (105) 2 (5) 039
HCoV 20 (58) 8 (61) 5 (5) 4 (53) 3 (75) 094
HMPV 14 (40) 5 (38) 6 (6) 0 (0) 3 (75) 014
Coinfection 67 (295) 29 (33) 18 (265) 15 (30) 5 (313) 076
Any viral infection 227 (654) 88 (672) 68 (68) 50 (658) 21 (525) 033
hAdV, human adenovirus; hRSV, human respiratory syncytial virus; RV/EV, rhinovirus/enterovirus; hBoV, human bocavirus; hPIV, human parainfluenza
virus; hCoV, human coronavirus; hMPV, human metapneumovirus.
Data are number and percentage in brackets.
Table 3. Contribution of respiratory viruses to severe acute respiratory illness among hospitalized patients in Cameroun as monoinfection or
coinfection
AdV RSV RV/EV hBoV PIV A/H3N2 hCoV hMPV Inf B A/H1N1p Total (N = 225)
AdV 49 9 8 9 4 1 2 2 0 0 95 (273)
RSV 26 2 1 0 3 1 0 0 0 46 (132)
RV/EV 17 4 0 0 1 1 0 0 40 (115)
hBoV 13 0 1 0 1 0 0 37 (106)
PIV 11 0 1 0 0 0 23 (66)
A/H3N2 16 0 0 0 0 22 (63)
hCoV 9 0 1 0 20 (57)
hMPV 8 0 0 14 (40)
Inf B 7 0 8 (23)
A/H1N1p 4 4 (11)
1 Virus 49 26 17 13 11 16 9 8 7 4 160 (705)
2 viruses 35 16 16 17 6 5 6 4 1 0 53 (233)
3 Viruses 10 4 6 7 5 1 4 2 0 0 13 (57)
4 Viruses 1 0 1 0 1 0 1 0 0 0 1 (04)
hAdV, human adenovirus; hRSV, human respiratory syncytial virus; RV/EV, rhinovirus/enterovirus; hBoV, human bocavirus; hPIV, human parainfluenza
virus; hCoV, human coronavirus; hMPV, human metapneumovirus.
Data are number and percentage in brackets.
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Figure 2. Number of each respiratory virus/
group of viruses detected as single or mixed
infections.
A B
C D
E F
G H
Figure 3. Seasonal distribution of respiratory viruses or group of viruses detected in children with SARI during September 2011 till September 2013.
Primary y-axis and bars describe the number of cases, while secondary y-axis and lines describe the monthly detection rate.
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number of samples collected during that period. On the
other hand, hAdV occurred throughout the study period
with no evident temporal patterns. hBoV occurred intermit-
tently all over the study period, while the prevalence of
remaining viral etiologies was low, ranging from 0 to 5
positive samples per month for each virus, numbers which
appeared insufficient to allow for the description of seasonal
patterns. Coinfections were observed throughout the study
period.
Discussion
The aim of this study has been to determine the viral
panorama of SARI in 374 hospitalized children during a 2-
year period in Cameroon. The data presented here are
unique, to the best of our knowledge. It represents viral
etiologies (17 respiratory viral targets) in children aged
≤15 years hospitalized for SARI in Cameroon. More impor-
tantly, this study describes the incidence of AdV and the
recently discovered hBoV in Cameroon for the first time.8
Our results demonstrate the potential importance of respi-
ratory viruses in the etiology of hospitalized children with
SARI in Cameroon.
Of 347 samples tested, at least one respiratory virus was
detected in 227 (645%). This detection rate is consistent
with results of other etiologic studies of hospitalized
children conducted in similar settings.16–20 Nonetheless,
this proportion appears to vary largely between countries.
Kwofie et al. recorded a lower percentage of 257% in
Ghana21 and Khor et al. recorded 264% in Malaysia.22
Higher percentages 942% in China,23 91% in France,24
and 90% in Alaska25 were reported by Zhang et al.,
Singleton et al., and Huguenin et al., respectively. Com-
parison among published studies is always difficult.
Possible reasons for these varying outcomes among studies
include true differences in epidemiology, differences in the
inclusion criteria for study population, diagnostic methods
used, panel of viral agents tested, climate, study duration,
and patients’ ages. Consider that all the above studies
included hospitalized children; lower prevalence recorded
by Khor et al. might have been due to their 27-year study
duration and laboratory methods (direct IF and viral
isolation) which are known to be less sensitive than
molecular techniques.25
The most prevalent virus detected in our study was AdV,
representing 273% of the total number of viruses observed.
This value is higher than that (08–133%) reported in most
other similar studies.16,17,22,26–28 It is nonetheless similar to
what was noted in Alaska24 and in Mozambique29 by
Singleton et al. (30%) and O’Callaghan-Gordo et al.
(21%). The serotypes B(3,7,21) and E(4) of AdV have been
implicated in more severe diseases including bronchitis or
pneumonia30 in the immunocompromised host and children
particularly. This finding shows that AdV could play a more
significant role than originally thought. Accordingly, addi-
tional efforts describing our associated serotypes will help to
further understand how much this virus contributes to
disease severity.
Unlike our results, most similar studies showed that hRSV
was the most prevalent viral pathogen.22,31–33 In our study,
hRSV was the second most frequent pathogen after hAdV
with merely 132% of 347 hospitalized children testing
positive. However, this proportion was similar to that
reported in other studies (57–15%).16,28,29,34 Unlike previ-
ous similar studies, RV/EV accounted for only 115% of
positivity in our study.17,18,24,26,29 HBoV was the fourth most
common virus with a prevalence of 106% in all cases. This
result is in line with the results of others authors, who have
reported a worldwide detection rate of hBoV ranges between
2 and 19% in nasopharyngeal samples.35 The remaining viral
etiologies were identified in 98%, 66%, 57%, and 23% for
influenza, HPIV, HCoV, and HMPV, respectively. These
results correspond with those reported by other
authors.23,27,32,33,36,37
As previously shown, we also found that virus-associated
hospitalization figures were significantly higher among
children (P = 003).27,28,38 According to reports, there is
always a higher incidence of viral respiratory infection in
children than in adults. This may be partially explained by
the lower detection rate of respiratory viruses in the elderly
due to reduced viral shedding in older age groups.39 HRSV,
the second most commonly virus detected in this study, has
been reported to be the leading cause of SARI in young
children.19,22,36 Nevertheless, we did not find a significant
age-specific prevalence in HRSV detection during this study.
This was probably due to the fact that our statistical analysis
was hampered by the limited size of study participants older
than 5 years. Headaches were negatively associated with
positives samples (P = 0003). However, as a majority of our
study population was made up of children unable to report
headaches, only 46 patients (133%) were taken into account
in the analysis.Multiple viral infections were observed in
295% of the patients with positive viral detection. This is a
very similar percentage to the one found by others
researchers.22,26,37 Bocavirus has been frequently implicated
in coinfections.17,19,25 Our results reflect those of other
studies in which hBoV was associated (358% versus 81%,
P < 0001) with multiple infections. Surprisingly, AdV and
picornaviruses were also most frequently involved in coin-
fections, which probably resulted from the fact that they were
detected throughout the year and were among the most
prevalent.
In spite of our intensive surveillance strategy with daily
recruitment, the number of inclusions was not stable over the
study period. Notwithstanding this lack of uniformity in
number of samples collected during the first (September
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2011 to November 2012) and second (December 2012 to
September 2013) periods, we were able to detect a seasonal
pattern thanks to the sufficient number of enrolled patients
during two consecutive years. We found that RSV cases were
detected mainly during the major rainfalls from September
to November, which is consistent with the data in the
literature.22,23,31 The seasonality of influenza virus is very
uncertain in tropical areas. The current study did not
confirm that influenza circulated between September and
November, as shown in our previous studies.13 This fact
might have contributed to the reduction in the inclusion rate
during the second period due to a true change in the
epidemiology of SARI. Indeed, that would have contributed
to reduce the numbers eligible patients in the second period
of the study. RV/EV and AdV circulated year-round, a
finding reported in other studies.17,23,28 For the remaining
viruses, no evident temporal patterns were observed. This
study is ongoing, however, and any changes in the seasonal
circulation will be detected.
Several points must be taken into consideration when
looking at our findings. Firstly, our study was conducted at
only one site, which might have underestimated the overall
detection rate for selected viruses. Likewise, the enrolled cases
may not be generalizable for the entire population of children
in Cameroon. Subsequently, as discussed by Broor et al.,38
there is no denial that some respiratory viruses can be
detected in asymptomatic children24,40,41 or shed for long
periods of time after infection.24,42 Hence, the role played by
the viruses detected in these SARI cases is less clear
considering that we did not evaluate respiratory specimens
from asymptomatic children without respiratory symptoms.
Otherwise, despite tests for a large panel of respiratory
viruses we did not evaluate bacterial etiologies, due to the
difficulty in obtaining adequate samples for culture. It has
been shown that bacterial pathogens may have been respon-
sible for SARI symptoms16; further studies will thus be
required to specify their role in SARI in Cameroon. Lastly,
although nurses in charge of recruitment were well trained,
they did not systematically record severe symptoms such as
convulsion, stridor, chest pain, inability to drink or breast-
feed, and outcomes of study participants. This limited our
ability to assert the clinical case severity and outcome of our
SARI cases. This situation also added a limitation to this
study regarding the representativeness of children included.
Notwithstanding its limits, this is the first study in
Cameroon to characterize 17 common respiratory viruses
in pediatrics with SARI during a 2-year consecutive period.
Using a multiplex rRT-PCR, we were able to identify a wide
variety of viruses and their seasonal patterns. In our
resource-limited setting, this process is particularly useful
for selecting only the major contributors to SARI and thereby
enhancing our existing surveillance systems. Additional
studies evaluating asymptomatic Cameroonian children will
be important to understanding the relationship between viral
carriage and disease. With this new method, we will also be
able to evaluate the role of viral loads in respiratory
infections in future research.
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